SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
295.80    10.40 (3.64%)
Bid:
296.80
Ask:
297.40
Spread: 0.60 (0.202%)
Market Cap: £1.03b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Proposed Placing

11 Apr 2012 07:00

RNS Number : 0721B
Breedon Aggregates Ld
11 April 2012
 



11 April 2012

Breedon Aggregates Limited

("Breedon Aggregates" or the "Company")

 

Proposed Placing of £15 million to Fund Future Acquisitions

 

Breedon Aggregates, the UK's largest independent aggregates business, has today announced a conditional placing of 83,333,335 ordinary shares of no par value (the "Placing Shares") with new and existing institutional investors and Directors, to raise approximately £15 million (before expenses) (the "Placing"). The Placing will provide Breedon Aggregates with additional cash resources to make further acquisitions and if appropriate reduce the indebtedness of the Company and its subsidiaries.

The Placing is conditional, inter alia, upon the passing by the Company's shareholders of certain of the resolutions proposed at the Company's Annual General Meeting to be held on Friday 20 April 2012 ("AGM"), to give the Directors power to allot ordinary shares (including the Placing Shares) on a non-pre-emptive basis. Marwyn Value Investors LP has signed an irrevocable undertaking to vote in favour of the resolutions at the AGM in respect of their holding of 146,223,698 ordinary shares representing 26.1 per cent. of the existing issued share capital.

Background to and reasons for the Placing

 

Breedon Aggregates' stated strategy is to grow via consolidation of the heavyside building materials sector. Since the reverse takeover of Breedon Holdings Limited in 2010, the Company has made two bolt-on acquisitions (C&G Concrete and Nottingham Readymix), for a total consideration of £11.7 million. The Company continues to seek opportunities to acquire similar businesses and the funds raised from the Placing may be used to provide additional cash resources for this purpose. The Company is currently in discussion with a number of potential vendors.

 

Details of the Placing

 

The Company, through its broker, Cenkos Securities plc ("Cenkos"), has conditionally raised approximately £15 million (before expenses) through the proposed issue of Placing Shares at 18 pence per share, which represents a discount of approximately 11.7 per cent. to the closing middle market price of 20.38 pence per ordinary share on 10 April 2012 (the last business day prior to the publication of this announcement). 

 

The issued share capital of the Company, as enlarged by the Placing, will be 644,338,789 ordinary shares. The Company does not currently hold any shares in treasury. This figure of 644,338,789 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Disclosure and Transparency Rules.

 

The Placing Shares once issued will represent approximately 12.9 per cent. of the Company's issued ordinary share capital immediately following admission (assuming no other ordinary shares are issued prior to such date).

 

Application will be made to the London Stock Exchange for the Placing Shares to be admitted to trading on AIM. It is expected that admission will become effective and that dealings in the Placing Shares will commence on AIM at 8.00 a.m. on Monday 23 April 2012.

The following Directors have committed to subscribe for new ordinary shares as part of the Placing:

Director

Commitment

Shares held post-Placing

% of enlarged share capital post-Placing

Peter Tom CBE

1,633,332

34,216,665

5.31

Simon Vivian

277,778

3,444,445

0.54

Ian Peters

111,112

1,944,445

0.30

Susie Farnon

200,000

1,400,000

0.22

David Warr

555,556

4,055,556

0.63

 

- ends -

For further information:

 

Breedon Aggregates Limited

Simon Vivian, Group Chief Executive

Ian Peters, Group Finance Director

01332 694010

Stephen Jacobs, Head of Communications

07831 764592

 

Cenkos Securities plc

Nicholas Wells / Max Hartley

020 7397 8900

 

More about Breedon Aggregates

 

Breedon Aggregates is the largest independent aggregates business in the UK, operating 26 quarries, 18 asphalt plants and 40 ready-mixed concrete plants in England and Scotland, and employing around 800 people. The group has strong asset backing, with nearly 200 million tonnes of mineral reserves and resources.

 

www.breedonaggregates.com

 

Important notes

Cenkos Securities Plc, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively for the Company in relation to the Placing and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Cenkos Securities Plc nor for providing advice in relation to the Placing or any other transaction or arrangement referred to in this document. Nothing in this paragraph shall serve to include or limit any responsibilities or liabilities Cenkos Securities Plc may have under the Financial Services and Markets Act 2000, as amended, or the regulatory regime established thereunder.

Neither this announcement, nor any part of it, constitutes an offer to sell or issue or the solicitation of an offer to buy, subscribe or acquire any new ordinary shares in the Company in any jurisdiction in which any such offer or solicitation would be unlawful and the information contained herein is not for publication or distribution, directly or indirectly, in or into the United States of America, Canada, Australia, the Republic of South Africa, the Republic of Ireland or Japan or any jurisdiction in which such publication or distribution would be unlawful.

This announcement includes statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "plans", "expects", "intends", "may", "will" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this announcement and include, but are not limited to, statements regarding the Company's intentions, beliefs or current expectations concerning, among other things, the Company's financial position, prospects, growth, strategies and expectations.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOELLFERSFIILIF
Date   Source Headline
17th Jul 202512:37 pmRNS-RNotice of live interactive presentation on Engage
30th Jun 20257:00 amRNSTotal Voting Rights
30th Jun 20257:00 amRNSBlock Listing Six Monthly Return
27th Jun 20254:10 pmRNSHolding(s) in Company
24th Jun 20251:00 pmRNSNotice of Interim Results
16th Jun 20254:42 pmRNSDirector/PDMR Shareholding
30th May 20259:41 amRNSTotal Voting Rights
6th May 20252:15 pmRNSHolding(s) in Company
2nd May 20253:34 pmRNSDirector/PDMR Shareholding
30th Apr 202512:46 pmRNSTotal Voting Rights
29th Apr 20254:55 pmRNSResult of AGM
29th Apr 20257:00 amRNSAGM Trading Update
17th Apr 20253:24 pmRNSHolding(s) in Company
15th Apr 20251:27 pmRNSDirector/PDMR Shareholding
15th Apr 20259:25 amRNSHolding(s) in Company
15th Apr 20259:23 amRNSHolding(s) in Company
9th Apr 20253:31 pmRNSHolding(s) in Company
8th Apr 20255:16 pmRNSDirector/PDMR Shareholding
8th Apr 20255:15 pmRNSDirector/PDMR Shareholding
31st Mar 20253:23 pmRNSTotal Voting Rights
26th Mar 20252:34 pmRNSHolding(s) in Company
17th Mar 202510:10 amRNS2024 Annual Report and Notice of AGM
12th Mar 20253:35 pmRNSApplication for Admission of Consideration Shares
7th Mar 20257:00 amRNS-RLive presentation via Investor Meet Company
6th Mar 202512:00 pmRNSCompletion of Acquisition
5th Mar 20257:01 amRNSAcquisition
5th Mar 20257:00 amRNSFinal Results
28th Feb 20251:56 pmRNSTotal Voting Rights
4th Feb 20259:25 amRNSNotice of Results
31st Jan 20257:00 amRNSTotal Voting Rights
31st Dec 20247:00 amRNSBlock listing six monthly return
31st Dec 20247:00 amRNSTotal Voting Rights
2nd Dec 20244:40 pmRNSDirector/PDMR Shareholding
29th Nov 20249:15 amRNSTotal Voting Rights
21st Nov 20247:00 amRNSNovember Trading Statement
12th Nov 20245:06 pmRNSDirector/PDMR Shareholding
31st Oct 20247:00 amRNSTotal Voting Rights
30th Sep 20241:55 pmRNSTotal Voting Rights
30th Aug 20248:49 amRNSTotal Voting Rights
31st Jul 202410:11 amRNSTotal Voting Rights
24th Jul 20247:00 amRNSInterim results 2024
11th Jul 20244:33 pmRNSHolding(s) in Company
28th Jun 20247:00 amRNSBlock listing six monthly return
28th Jun 20247:00 amRNSTotal Voting Rights
25th Jun 20242:38 pmRNSNotice of Results
13th Jun 20243:53 pmRNSDirector/PDMR Shareholding
12th Jun 20245:16 pmRNSHolding(s) in Company
12th Jun 20244:31 pmRNSDirector/PDMR Shareholding
11th Jun 20244:28 pmRNSHolding(s) in Company
6th Jun 20242:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.